Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Licenses Oxford Gene Tech's DNA Sequence Variation Patents

NEW YORK (GenomeWeb News) — Illumina has licensed Oxford Gene Technology patents that will enable Illumina to detect DNA sequence variations, OGT said today.
 
Under the deal, OGT has granted Illumina access to the property through the life of the patents and provides “certain rights with respect to SNP genotyping,” OGT said.
 
Illumina CEO Jay Flatley said the licensing agreement is “relevant to a portion of our products and will not materially impact our expected financial results."
 
Financial terms of the deal were not released.
 
The news comes one month after Illumina said it plans to acquire next-generation DNA-sequencing technology company Solexa for around $600 million in stock.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.